Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses-Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
(öffnet in neuem Fenster)
Autoren:
rea Vannini 1,2,†ORCID,Federico Parenti 1,†ORCID,Catia Barboni 3ORCID,Cristina Forghieri 1,Valerio Leoni 1,Mara Sanapo 4,Daniela Bressanin 1,Anna Zaghini 3ORCID,Gabriella Campadelli-Fiume 1,*,‡ andTatiana Gianni 1,*,‡
Veröffentlicht in:
Cancers, 2023, ISSN 2072-6694
Herausgeber:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/cancers15164042
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy
(öffnet in neuem Fenster)
Autoren:
Andrea Vannini 1,2,†ORCID,Federico Parenti 1,†ORCID,Cristina Forghieri 1,Gaia Vannini 1,Catia Barboni 3,Anna Zaghini 3ORCID,Tatiana Gianni 1,*,‡ andGabriella Campadelli-Fiume 1,*,‡
Veröffentlicht in:
Cancers, 2024, ISSN 2072-6694
Herausgeber:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/cancers16061143
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
(öffnet in neuem Fenster)
Autoren:
Andrea Vannini1,2 Federico Parenti1 Cristina Forghieri1 Catia Barboni3 Anna Zaghini3 Gabriella Campadelli-Fiume1*†Tatiana Gianni1*†
Veröffentlicht in:
Front. Mol. Biosci., 2023, ISSN 2296-889X
Herausgeber:
Frontiers
DOI:
10.3389/fmolb.2023.1149973
